openPR Logo
Press release

Nasal Polyposis - Pipeline Review, H2 2017

10-25-2017 04:03 PM CET | Health & Medicine

Press release from: ReportsWorldwide

Nasal Polyposis - Pipeline Review, H2 2017

Nasal Polyposis - Pipeline Review, H2 2017

ReportsWorldwide has announced the addition of a new report title Nasal Polyposis - Pipeline Review, H2 2017 to its growing collection of premium market research reports.

Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyposis - Pipeline Review, H2 2017, provides an overview of the Nasal Polyposis (Ear Nose Throat Disorders) pipeline landscape.

Nasal polyps (NP) are non cancerous growths within the nose or sinuses. Symptoms include runny nose, snoring, itchiness, persistent stuffy, facial pain, loss of taste. Risk factors include asthma, cystic fibrosis, Churg-Strauss syndrome and allergic fungal sinusitis. Treatment includes corticosteroids, antihistamines to treat allergies and antibiotics to treat a chronic or recurring infection.

To Enquire about this Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41671

Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Nasal Polyposis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Nasal Polyposis (Ear Nose Throat Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Nasal Polyposis (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasal Polyposis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III and Phase II stages are 1, 1 and 3 respectively.

Nasal Polyposis (Ear Nose Throat Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Nasal Polyposis (Ear Nose Throat Disorders).
- The pipeline guide reviews pipeline therapeutics for Nasal Polyposis (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Nasal Polyposis (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Nasal Polyposis (Ear Nose Throat Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Nasal Polyposis (Ear Nose Throat Disorders)

To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/nasal-polyposis-pipeline-review-h2-2017

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Nasal Polyposis (Ear Nose Throat Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Nasal Polyposis (Ear Nose Throat Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston,
MA 02110
US
Phone +1 (617) 398-1947

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nasal Polyposis - Pipeline Review, H2 2017 here

News-ID: 786167 • Views: 156

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for Nasal

Global Nasal Cannulas Market Research Report
This report studies the global Nasal Cannulas market status and forecast, categorizes the global Nasal Cannulas market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Medtronic BD Salter Labs Teleflex Westmed Smiths Medical Flexicare A-M Systems Intersurgical Geographically, this report studies the
Nasal Polyps Therapeutics Pipeline Review 2018
Nasal polyps are the type of lesions that arises from the mucosa of the nasal cavity. The cause of nasal polyps is still unknown. According to researchers, chronic inflammation in the nose and nasal sinuses are responsible for the occurrence of nasal polyps. Nasal polyps can be symptomatized by the runny nose, postnasal drip, absent sense of smell, facial pain, pain in upper teeth, snoring, persistent stuffiness, and sense of
Nasal Aspirator Market
Nasal aspirator is a small medical device which is used to clear the nose of a baby. When babies suffered from cold, the snot (nasal mucus) develop in their nose. Unfortunately, babies do not know how to blow their nose to clear, nasal aspirators, however, work effectively in clearing up their stuffy nose and give them immediate relief from breathlessness. A nasal respirator is cheap and is easy to use.
Absorbable Nasal Implant Devices Market
Absorbable nasal implants are used to treat nasal blockage or obstructions and allow better breathing and sleep to the patient. Nasal airway obstruction can be caused by several factors, including septal deviation, enlarged turbinates, and weakened upper and/or lower lateral nasal wall cartilage, which can lead to nasal valve collapse (vestibular stenosis). Symptoms include stuffiness, congestion or an inability to breathe through one or both nostrils. The nasal valve
Nasal Polyposis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Nasal Polyposis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyposis - Pipeline Review, H1 2017, provides an overview of the Nasal Polyposis (Ear Nose Throat Disorders) pipeline landscape. Nasal polyps (NP) are non cancerous growths within the nose or sinuses. Symptoms include runny nose,
Global Nasal Cannula Market Research Report 2016
Notes: Production, means the output of Nasal Cannula Revenue, means the sales value of Nasal Cannula To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=898940&type=E This report studies Nasal Cannula in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Philips Respironics, Inc ResMed Inc Fisher & Paykel Healthcare Corporation Limited Intersurgical Ltd GE Healthcare All Pro Oxygen